Last reviewed · How we verify
Psychotic disorder
Approved treatments
- Thorazine · Generic (originally Rhône-Poulenc/Sanofi)
- Moditen Enanthate · Bristol-Myers Squibb
- Tindal · Merck & Co.
- Haldol · Johnson & Johnson (Janssen)
- Sordinol
Sordinol works by blocking the 5-hydroxytryptamine receptor 6, which helps to regulate mood and behavior. - Psyquil
- Prolixin Decanoate · Bristol-Myers Squibb
- Prolixin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Psychotic disorder patent landscape — cliff calendar, originator estates, attackable patents
- Psychotic disorder treatment landscape brief
- Psychotic disorder treatment updates RSS
Frequently asked questions about Psychotic disorder
What drugs treat Psychotic disorder?
Tracked treatments include Thorazine, Moditen Enanthate, Tindal, Haldol, Sordinol, Psyquil, Prolixin Decanoate, Prolixin.
What is the treatment for Psychotic disorder?
Standard treatment for Psychotic disorder includes Thorazine, Moditen Enanthate, Tindal, Haldol, Sordinol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Psychotic disorder patent cliff · Psychotic disorder CI report
- Treatment: Thorazine · Generic (originally Rhône-Poulenc/Sanofi)
- Treatment: Moditen Enanthate · Bristol-Myers Squibb
- Treatment: Tindal · Merck & Co.
- Treatment: Haldol · Johnson & Johnson (Janssen)
- Treatment: Sordinol
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing